Clinical Trial Update: Serum Neurofilament-light Chain and GFAP Levels in Patients From the OFSEP Cohort at Different Landmarks of Multiple Sclerosis

View source ↗

Summary

This clinical trial update investigates serum neurofilament-light chain and GFAP levels in people with multiple sclerosis from the OFSEP cohort at different dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Centre Hospitalier Universitaire de Nīmes | Conditions: Multiple Sclerosis | Status: RECRUITING